American Eagle Outfitters Inc. (NYSE: AEO) raised its fiscal fourth-quarter operating income outlook Monday, citing robust holiday demand and improved margins.

American Express is downgraded from "Buy" to "Hold" as shares approach fair value ahead of Q4 earnings. AXP's strong Q3 results, robust card usage, and Platinum Card refresh support mid-teens EPS growth guidance. Valuation is now stretched, with a 21x P/E multiple and mixed technical signals suggesting limited near-term upside.

Krystal Biotech, Inc. (KRYS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Five Below, Inc. (FIVE) Presents at ICR Conference 2026 Transcript

I see the entire bull case on Critical Metals Corp. hinging on funding. Tanbreez needs roughly $500M Greenland CapEx plus $1B downstream, far beyond the company's $87M in pro forma cash. A big catalyst could be the U.S. stake in the company, which will unlock other possible funding streams, like a $120M loan from EXIM. Qaqortoq pilot plant section targeted by May 2026, and Romania 300–500 kg/hr POC pilot commissioning in Q2 2026.

CVX is accelerating Venezuelan crude exports to ease storage bottlenecks and unlock up to $700 million in annual cash flow amid shifting geopolitics.

BMNR has surged 298% since going public. fueled by Ethereum accumulation and a shareholder-friendly strategy.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

It's official. Apple has chosen to work with Google, a longtime partner, to power AI features like Siri.

New York, New York--(Newsfile Corp. - January 12, 2026) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a shareholder and consumer rights litigation firm, is investigating whether Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 12, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) ("Integer" or the "Company") on behalf of investors who purchased or otherwise acquired Integer securities during the period of July 25, 2024 through October 22, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Integer securities during the Class Period may, no later than February 9, 2026, seek to be appointed as a lead plaintiff representative of the class.

Shares of banks and credit card companies moved lower after US president Donald Trump proposed capping interest rates on cards to 10% for a year starting January 20, rekindling an idea initially put forward during his 2024 presidential campaign. The average interest rate for credit cards in the US is reportedly about 20%.

Palantir's U.S. commercial business is on fire thanks to AI and could help fuel a further reacceleration of growth, beyond the impressive performance the company has posted recently.

An analyst is ending his bearish call on the ad-tech stock, which was the biggest S&P 500 loser of 2025.

The "Sell America" trade is top of mind after Federal Reserve Chair Jerome Powell said he's under criminal investigation. The dollar is dropping in Monday's session while precious metals rally to records.

As two major streaming platforms—Warner Bros. and Netflix—prepare for a merger, concerns continue to be voiced about the implications of the deal, which represents more consolidation in the media business.

JBHT's fourth-quarter 2025 revenues are expected to have declined year over year. Higher net interest expense might have hurt the bottom line.

APLD shares spike after Q2 revenues soar 250%, underscoring strong execution while leaving questions around valuation and losses.

Global Payments CEO Cameron Bready joins 'Squawk on the Street' to discuss the company's acquisition of Worldpay, address concerns about the deal, and more.

Eli Lilly Chief Financial Officer Lucas Montarce says the company's weight-loss pill is on track to be approved in the US as early as the second quarter of this year. He speaks to Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco.